Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock.
Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock. J Thorac Cardiovasc Surg. 2018 03; 155(3):1059-1068.